Efficacy of a Multistrain Synbiotic Treatment in Acute and Post-Acute COVID-19 Patients: A Double-Blind, Placebo-Controlled Randomized Trial.
Maria Letizia GiancolaAndrea FontanaConcetta PanebiancoAntonio MazzarelliAlessia BeccacecePatrizia De MarcoGiovanna CocomazziChiara De GiuliGermana GrassiCarla FontanaGiorgio Maria BaldiniViviana ContuMassimiliano CopettiFrancesco PerriEmanuele NicastriValerio PazienzaPublished in: Microorganisms (2024)
Our data suggest that modulating the gut microbiota in acute disease through administration of a specific symbiotic formula could be a useful strategy in the frame of SARS-CoV-2 infections.
Keyphrases
- liver failure
- sars cov
- respiratory failure
- drug induced
- placebo controlled
- hepatitis b virus
- randomized controlled trial
- signaling pathway
- clinical trial
- big data
- squamous cell carcinoma
- radiation therapy
- respiratory syndrome coronavirus
- double blind
- human milk
- smoking cessation
- preterm infants
- phase iii
- replacement therapy
- acute respiratory distress syndrome